Rituximab-responsive Guillain-Barré Syndrome Following Allogeneic Hematopoietic SCT

Bone Marrow Transplant. 2008 Jul;42(1):71-2. doi: 10.1038/bmt.2008.81. Epub 2008 Apr 7.

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Guillain-Barre Syndrome / drug therapy*
  • Guillain-Barre Syndrome / immunology
  • Guillain-Barre Syndrome / virology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Herpesvirus 4, Human / drug effects
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Rituximab
  • Transplantation, Homologous
  • Viremia / drug therapy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab